Back
VHLHGNC Autosomal dominantPubMedRecurrent variant

Clinical and Genetic Characterization of Russian Patients with von Hippel-Lindau Syndrome.

Mikhaylenko DS, Vasserman NN, Kuryakova NB, et al. — Int J Mol Sci 2026 · October 2026
Relevance score
7/10
Disease / domain
Von Hippel-Lindau syndrome
Source
PubMed
PMID 42884048

Gene / mechanism

VHL

Germline VHL variants: mostly missense (60.3%), about 88% of which affect the HIF-α- and ELOC-binding sites of pVHL

Summary

The VHL gene was analysed in 535 Russian patients referred for suspected von Hippel-Lindau syndrome, using Sanger sequencing, MLPA and, in some cases, high-throughput sequencing. In total, 177 causative variants were identified (129 point mutations and 48 large deletions), mostly missense (60.3%) clustered at codons 167, 88 and 78. Carriers had central nervous system (69.7%) and retinal (41.4%) haemangioblastomas, clear-cell renal carcinoma (27.3%) and phaeochromocytoma (7.1%); multi-organ involvement was far more frequent than in patients without a variant (78.8% vs 21.1%), whereas an isolated clear-cell renal carcinoma, even before age 60, had a positive predictive value of only 14.7%. The p.Glu70Lys variant was found only in four patients of East Asian ancestry, and the nonsense variant p.Arg161Ter was more frequent in patients of Turkic than Slavic ethnicity (30.0% vs 2.5%). Testing of 87 relatives identified 41 carriers.

Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.

Analysis

A large national series, useful above all for one figure: the 14.7% positive predictive value of an isolated clear-cell renal carcinoma, which helps prioritise indications for VHL testing. Ancestry-enriched variants (p.Glu70Lys, p.Arg161Ter) are worth knowing for interpretation in under-represented populations. Descriptive study, without follow-up or variant-level penetrance data.

Analysis by Dr Thibaut Benquey

Why this score?

Impact 2/3Evidence 2/3Novelty 1/2Sample 1/1Publication 1/1

Clinical impact: 2/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 7/10

Keywords

von Hippel-LindauVHLhaemangioblastomaclear-cell renal carcinomagenotype-phenotype correlation

More articles on VHL

Weekly report in your inbox

Every Wednesday · Annotated selection · Free · Unsubscribe anytime